Synopsis of recent research by authors named "Yoshiaki Marumo"
- Yoshiaki Marumo's recent research focuses on the clinical implications of infectious adverse events in immunocompromised patients, particularly exploring CMV reactivation during anti-CD38 monoclonal antibody therapy and the immunological responses post-COVID-19 vaccination in hematological disorder patients.
- His studies emphasize the effectiveness and challenges of vaccines in immunocompromised populations with disorders like plasma cell dyscrasia and malignant lymphoma, highlighting the variability of humoral immune responses to mRNA vaccines.
- Marumo also contributes valuable insights into genetic diagnostics, exemplified by his work on multigene panel testing in difficult-to-diagnose tumors and developing clinical scoring systems for predicting VEXAS syndrome, which is crucial for personalized patient care.
